These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Circ-HIPK3 regulates YAP1 expression by sponging miR-381-3p to promote oral squamous cell carcinoma development. Bi L, Zhang C, Yao Y, He Z. J Biosci; 2021; 46():. PubMed ID: 33737493 [Abstract] [Full Text] [Related]
4. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells. Wang F, Ye LJ, Wang FJ, Liu HF, Wang XL. Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461 [Abstract] [Full Text] [Related]
6. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data. Wang Y, Jiang Y, Chen L. J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676 [Abstract] [Full Text] [Related]
8. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. Huang WC, Jang TH, Tung SL, Yen TC, Chan SH, Wang LH. J Exp Clin Cancer Res; 2019 Feb 19; 38(1):89. PubMed ID: 30782177 [Abstract] [Full Text] [Related]
10. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma. Li C, Lin XF, Wang JN, Ren XS. Eur Rev Med Pharmacol Sci; 2020 Apr 19; 24(7):3701-3709. PubMed ID: 32329846 [Abstract] [Full Text] [Related]
11. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X. Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408 [Abstract] [Full Text] [Related]
12. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1. Li B, Lv Y, Zhang C, Xiang C. J Oral Pathol Med; 2023 Mar 16; 52(3):216-225. PubMed ID: 36661031 [Abstract] [Full Text] [Related]